Gardiner Nancy B boosted its stake in Danaher Corporation (NYSE:DHR) by 20.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,272 shares of the conglomerate’s stock after buying an additional 2,087 shares during the period. Danaher Corporation accounts for about 2.1% of Gardiner Nancy B’s portfolio, making the stock its 20th largest position. Gardiner Nancy B’s holdings in Danaher Corporation were worth $1,035,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. BlackRock Inc. raised its stake in shares of Danaher Corporation by 2,530.9% in the first quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock valued at $3,247,398,000 after buying an additional 36,524,795 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Danaher Corporation by 3.9% in the first quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock valued at $3,503,962,000 after buying an additional 1,530,015 shares in the last quarter. MARSHALL WACE ASIA Ltd bought a new stake in shares of Danaher Corporation during the first quarter valued at approximately $116,462,000. Marshall Wace North America L.P. bought a new stake in shares of Danaher Corporation during the first quarter valued at approximately $116,462,000. Finally, Parnassus Investments CA raised its stake in shares of Danaher Corporation by 15.3% in the first quarter. Parnassus Investments CA now owns 8,622,528 shares of the conglomerate’s stock valued at $712,738,000 after buying an additional 1,143,284 shares in the last quarter. 76.12% of the stock is currently owned by institutional investors.

Danaher Corporation (NYSE DHR) opened at 82.16 on Friday. The firm has a market capitalization of $57.08 billion, a PE ratio of 26.22 and a beta of 1.03. The firm has a 50-day moving average price of $82.08 and a 200-day moving average price of $84.16. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.01.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.90 earnings per share. Equities analysts expect that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

WARNING: “Gardiner Nancy B Purchases 2,087 Shares of Danaher Corporation (DHR)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/26/gardiner-nancy-b-purchases-2087-shares-of-danaher-corporation-dhr.html.

DHR has been the topic of several recent analyst reports. Zacks Investment Research lowered Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. Citigroup Inc. set a $96.00 price objective on Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Royal Bank Of Canada reiterated a “hold” rating and issued a $88.00 price objective on shares of Danaher Corporation in a research report on Wednesday, July 12th. Finally, Wells Fargo & Company assumed coverage on Danaher Corporation in a research report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $91.76.

In related news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the transaction, the insider now directly owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the completion of the transaction, the director now directly owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The disclosure for this sale can be found here. Over the last three months, insiders sold 27,808 shares of company stock valued at $2,296,236. 12.20% of the stock is owned by insiders.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.